Form D — Tempest Therapeutics, Inc.
0001231919-26-000307 · filed Apr 3, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,999,539
- Reported amount sold
- $1,999,539
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Tempest Therapeutics, Inc.
- CIK
- 1544227
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE, California 94005 - Phone
- 415-798-8589
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matthew Angel · Executive OfficerBrisbane, California Find on LinkedIn ↗
-
Nicholas Maestas · Executive OfficerBrisbane, California Find on LinkedIn ↗
-
Michael Raab · DirectorBrisbane, California Find on LinkedIn ↗
-
Christine Pellizzari · DirectorBrisbane, California Find on LinkedIn ↗
-
Ronit Simantov · DirectorBrisbane, California Find on LinkedIn ↗
-
Stephen Brady · DirectorBrisbane, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗